Clinical Trials · NCT00960661
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 1,036
- Start date
- Sep 2009
- Locations
- 95 sites, 18 countries
- Primary endpoint
- Change in Glycosylated Hemoglobin (HbA1c) From Baseline to Week 30